Prophylaxis of infections post-allogeneic ...
Document type :
Article dans une revue scientifique: Article original
PMID :
Permalink :
Title :
Prophylaxis of infections post-allogeneic transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Author(s) :
Lewalle, Philippe [Auteur]
Pochon, Cecile [Auteur]
Michallet, Mauricette [Auteur]
Turlure, Pascal [Auteur]
Brissot, Eolia [Auteur]
Paillard, Catherine [Auteur]
Puyade, Mathieu [Auteur]
Roth-Guepin, Gabrielle [Auteur]
Yakoub-Agha, Ibrahim [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]
Lille Inflammation Research International Center - U 995 [LIRIC]
Chantepie, Sylvain [Auteur]
Pochon, Cecile [Auteur]
Michallet, Mauricette [Auteur]
Turlure, Pascal [Auteur]
Brissot, Eolia [Auteur]
Paillard, Catherine [Auteur]
Puyade, Mathieu [Auteur]
Roth-Guepin, Gabrielle [Auteur]
Yakoub-Agha, Ibrahim [Auteur]

Lille Inflammation Research International Center - U 995 [LIRIC]
Lille Inflammation Research International Center - U 995 [LIRIC]
Chantepie, Sylvain [Auteur]
Journal title :
Bulletin du cancer
Abbreviated title :
Bull Cancer
Publication date :
2019-01-04
ISSN :
1769-6917
English keyword(s) :
Prophylaxis
Allogeneic hematopoietic stem cell transplantation
Infectious complications
Allogeneic hematopoietic stem cell transplantation
Infectious complications
English abstract : [en]
Allogeneic hematopoietic stem cell transplantation is a curative treatment for many hematological diseases. However, this procedure causes the patient to be susceptible to infection. Prophylactic treatments are administered ...
Show more >Allogeneic hematopoietic stem cell transplantation is a curative treatment for many hematological diseases. However, this procedure causes the patient to be susceptible to infection. Prophylactic treatments are administered in clinical practice even thought the level of evidence of their effectiveness is not always high. In addition, changes in the transplantation procedures - use of reduced intensity conditioning, development of alternative graft sources - must lead to a rethinking of attitudes towards prophylaxis. Our working group based its recommendations on a review of referential articles and publications on the subject found in the literature. These recommendations concern the prophylaxis of infections caused by HSV1, HSV2, varicella zoster, and hepatitis B, as well as anti-bacterial and digestive decontamination prophylaxis, prevention of pneumocystis, toxoplasmosis, tuberculosis, as well as prophylaxis of fungal infections. Other infectious agents usually involved in infections post-allotransplant have been the subject of another set of recommendations from the French Society of Bone Marrow Transplantation and Cellular Therapy.Show less >
Show more >Allogeneic hematopoietic stem cell transplantation is a curative treatment for many hematological diseases. However, this procedure causes the patient to be susceptible to infection. Prophylactic treatments are administered in clinical practice even thought the level of evidence of their effectiveness is not always high. In addition, changes in the transplantation procedures - use of reduced intensity conditioning, development of alternative graft sources - must lead to a rethinking of attitudes towards prophylaxis. Our working group based its recommendations on a review of referential articles and publications on the subject found in the literature. These recommendations concern the prophylaxis of infections caused by HSV1, HSV2, varicella zoster, and hepatitis B, as well as anti-bacterial and digestive decontamination prophylaxis, prevention of pneumocystis, toxoplasmosis, tuberculosis, as well as prophylaxis of fungal infections. Other infectious agents usually involved in infections post-allotransplant have been the subject of another set of recommendations from the French Society of Bone Marrow Transplantation and Cellular Therapy.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
CHU Lille
Inserm
Université de Lille
Inserm
Université de Lille
Submission date :
2019-10-22T08:16:37Z